Making sense of emerging evidence on the non-specific effects of the BCG vaccine on malaria risk and neonatal mortality
Saved in:
| Main Authors: | Gemma Moncunill, Carlota Dobaño |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-03-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/5/3/e002301.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland
by: Saba Savul, et al.
Published: (2023-12-01) -
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting
by: Nigel Curtis, et al.
Published: (2019-12-01) -
Role of malaria exposure and off-target responses on RTS,S/AS02A vaccine immunogenicity and protection in Mozambican children
by: Elisa Fuentes, et al.
Published: (2025-06-01) -
Immune status of children with complications of BCG/BCG-M vaccination
by: T. A. Sevostyanova, et al.
Published: (2020-02-01) -
Parents’ perspectives of the new neonatal BCG vaccination pathway in England: a qualitative study
by: Kate Bisset, et al.
Published: (2025-08-01)